Overview

A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea

Status:
Completed
Trial end date:
2019-11-05
Target enrollment:
Participant gender:
Summary
This study is conducted to investigate the effects of ACT-541468 on nighttime respiratory function in patients with mild to moderate obstructive sleep apnea
Phase:
Phase 1
Details
Lead Sponsor:
Idorsia Pharmaceuticals Ltd.